Zobrazeno 1 - 10
of 745
pro vyhledávání: '"Suemasu, K."'
Autor:
Hozumi, Y. *, Suemasu, K., Takei, H., Aihara, T., Takehara, M., Saito, T., Ohsumi, S., Masuda, N., Ohashi, Y.
Publikováno v:
In Annals of Oncology August 2011 22(8):1777-1782
Publikováno v:
In Respiratory Medicine March 2000 94(3):214-220
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Surgical Endoscopy. 14:587-591
In order to achieve urgent restoration of the airways in tracheobronchial stenosis and to make stent placement simpler and safer, we developed a method that allows combined bougienage and balloon dilation via the use of a conventional tracheal tube.
Publikováno v:
Surgical Endoscopy. 12:1155-1158
Video-assisted thoracoscopic surgery (VATS) has been reported to have a higher pneumothorax recurrence rate than limited axillary thoracotomy (LAT). We investigated the cause of pneumothorax recurrence after VATS by comparing surgical results for VAT
Autor:
Suemasu K
Publikováno v:
Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 33:67-71
Publikováno v:
Surgical endoscopy. 16(4)
Bullectomy for primary spontaneous pneumothorax has been associated with high postoperative recurrence rates when video-assisted thoracoscopic surgery (VATS) has been used rather than thoracotomy. The aim of this study was to evaluate the efficacy an
Publikováno v:
Europe PubMed Central
A patient with lung and pleural metastases from breast cancer treated effectively with toremifene is reported. A 62-year-old woman underwent mastectomy for breast cancer, and had high levels of estrogen and progesterone receptor. After 2-years of adj
Publikováno v:
Respiratory medicine. 94(3)
Assisted pressure control ventilation (PCV) via a min-tracheostomy tube (MTT) was conducted to improve gas exchange and reduce the work of breathing of lung cancer patients after surgery.Thirty-two patients with lung cancer underwent lobectomy and we
Publikováno v:
Europe PubMed Central
Twenty-four eligible patients (23 of whom were evaluated) with advanced and metastatic breast cancer were treated at the Saitama Cancer Center every 4 weeks with pirarubicin (30 mg/m2 i.v., day 1 and 8), cyclophosphamide (200 mg/m2 div, day 1 and 8)